New! Sign up for our free email newsletter.
Science News
from research organizations

Antibiotics may reduce the ability of immune cells to kill bacteria

Researchers found that in mice, antibiotics can directly remodel the biochemical environment of cells during infection, sometimes deleteriously

Date:
November 30, 2017
Source:
Broad Institute of MIT and Harvard
Summary:
A new study has shown that antibiotics can reduce the ability of mouse immune cells to kill bacteria, and that changes to the biochemical environment directly elicited by treatment can protect the bacterial pathogen.
Share:
FULL STORY

Antibiotics normally act in concert with an organism's immune system to eliminate an infection. However, the drugs can have broad side effects, including eliminating "good" bacteria in the course of fighting off a pathogen. A new study led by researchers from the Broad Institute of MIT and Harvard, MIT, and the Wyss Institute for Biologically Inspired Engineering has shown that antibiotics can also reduce the ability of mouse immune cells to kill bacteria, and that changes to the biochemical environment directly elicited by treatment can protect the bacterial pathogen. The work was published in Cell Host & Microbe.

"Antibiotics interact with cells, particularly immune cells, in ways we didn't expect," said co-first author Jason Yang, a postdoctoral scholar at the Broad Institute and MIT. "And the biochemical context, altered by antibiotics and cells in the surrounding tissue, matters when you're trying to predict how a drug might work in different people or in different infections."

In the face of the growing threat of antibiotic resistance, understanding the myriad impacts of antibiotics is also a critical goal for researchers and clinicians formulating better treatments. Senior author James Collins -- an institute member at Broad, professor at MIT, and core faculty member at the Wyss Institute -- and his lab have previously shown that several types of antibiotics can damage mitochondria in mice and in human epithelial cells, and that bacterial susceptibility to drugs can be affected by small molecules, called metabolites, released by cells as intermediates of their metabolic reactions.

Yang and his colleagues suspected that antibiotic treatment might further alter the infection microenvironment in ways that impact bacteria and immune cells. To investigate, the team treated mice infected by Escherichia coli bacteria with a commonly used antibiotic called ciprofloxacin, administered through the animals' drinking water at concentrations relative to what a human would receive, and quantified the biochemical changes.

The researchers found that the antibiotic treatment elicited systemic changes in metabolites -- not by influencing the microbiome, but by acting directly on the mouse tissues. On further investigation, the team determined that metabolites released by mouse cells made E. coli more resistant to ciprofloxacin. Antibiotic exposure also impaired immune function by inhibiting respiratory activity in immune cells: Macrophages treated with ciprofloxacin were less able to engulf and kill E. coli bacteria.

"You generally assume that antibiotics will significantly impact the bacterial cells, and yet here they seem to be triggering responses in mammalian cells," said Collins. "The drugs are producing changes that are actually counterproductive to the treatment effort. They reduce the bacterial susceptibility to antibiotics, and the drugs themselves reduce the functional benefit of the immune cells."

The results highlight the potential of antibiotics to modulate the immune system, and reveal the importance of the metabolic microenvironment in resolving an infection. "Aspects of this work indicate that biochemical diversity could be a driver of different drug treatment outcomes," said Yang. "If we have a better understanding of the specific effects that antibiotics can have on different cells, that may help us make decisions about how to better treat infection."

Translating the findings to human health will require more follow-up work. "We need to do additional animal studies under a broader range of conditions with a broader range of antibiotics, and potentially measure metabolites in human patients undergoing treatment, to see what else might be happening," said Collins.


Story Source:

Materials provided by Broad Institute of MIT and Harvard. Note: Content may be edited for style and length.


Journal Reference:

  1. Jason H. Yang, Prerna Bhargava, Douglas McCloskey, Ning Mao, Bernhard O. Palsson, James J. Collins. Antibiotic-Induced Changes to the Host Metabolic Environment Inhibit Drug Efficacy and Alter Immune Function. Cell Host & Microbe, 2017; DOI: 10.1016/j.chom.2017.10.020

Cite This Page:

Broad Institute of MIT and Harvard. "Antibiotics may reduce the ability of immune cells to kill bacteria." ScienceDaily. ScienceDaily, 30 November 2017. <www.sciencedaily.com/releases/2017/11/171130141100.htm>.
Broad Institute of MIT and Harvard. (2017, November 30). Antibiotics may reduce the ability of immune cells to kill bacteria. ScienceDaily. Retrieved March 28, 2024 from www.sciencedaily.com/releases/2017/11/171130141100.htm
Broad Institute of MIT and Harvard. "Antibiotics may reduce the ability of immune cells to kill bacteria." ScienceDaily. www.sciencedaily.com/releases/2017/11/171130141100.htm (accessed March 28, 2024).

Explore More

from ScienceDaily

RELATED STORIES